Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to... (uot; shares Prof Sarbjit who has done ov...)

Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller

Date:12/29/2008

uot; shares Prof Sarbjit, who has done over 60 such surgeries.

He says, "I expect this to really take off in time but for now, we remain one of a few places in the world that offer this."

Fitbone surgery is presently available in only selected medical centers in Europe and Asia. In Singapore, the Fitbone procedure costs around US $42,000 per telescope nail.

About SingaporeMedicine:
Launched in 2003, SingaporeMedicine is a multi-agency government-industry partnership committed to strengthening Singapore's position as Asia's leading medical hub and international health care destination. Led by the Ministry of Health of Singapore, SingaporeMedicine is supported by three government agencies: the Economic Development Board, which develops industry capabilities, the International Enterprise Singapore, which fosters regionalism by Singapore-based health care players, and the Singapore Tourism Board, which markets Singapore as a healthcare destination to inbound international patients and develops associated people-oriented services.(www.singaporemedicine.com).

###

Read the full story at http://www.prweb.com/releases/singapore-medicine/asia-leading-medical-hub/prweb1787264.htm

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine news :

1. A*STARs Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia
2. Healthy Travel Media Launches Second Edition of Patients Beyond Borders Singapore Edition
3. Singapore Caters to Middle East Medical Travelers with Arabic Version of Patients Beyond Borders-Singapore Edition
4. Singapore Medicine - First in South East Asia to Offer Robotic Surgery for Gynaecologic Cancers
5. Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore
6. Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion
7. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
8. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
9. Marian Koshland Science Museum forms partnership with Science Center Singapore
10. Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.
11. Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore

Post Your Comments:

Related Image:

Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller

(Date:12/5/2009)NEW ORLEANS, Dec. 5 There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in orde

(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w

(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s

(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation

(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div

Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8 Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2 Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3 Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4 Health News:Never Married, Over 40, Well-Adjusted 2 Health News:Never Married, Over 40, Well-Adjusted 3 Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2 Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3 Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4 Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2

[0] New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer [0] New Gene Findings Will Help Guide Treatment in Infant Leukemia [0] Never Married, Over 40, Well-Adjusted [0] AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share

...ealthy -- lining to the miserable cloud of allergy... just may help prevent cancer -- particularly colo..., lung and gastrointestinal tract cancer, accordin...Cornell professor of neurobiology and behavior, wh...

...to Record High, BEDFORD, Mass., Nov. 11 Hologic,... leading developer, manufacturer,and supplier of p...rgical,products dedicated to serving the healthcar..., -- Record revenues of $442.5 million. -- Recor...

... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ...practice, today announced financial results for th...Quarter 2008 Highlights:, -- Net revenue increa...over-year to 692,000 -- Income from operations r...

...ate autographed jerseys for eBay,auction to help S...nn., Nov. 11 Minnesota,Timberwolves, rookie Kevin...ief for St. Jude (http://www.stjude.org/rookierel...of the campaign, Love joins,the NBA,s top rookies ...

...)) provided dentistry to the Community of ...employees, affiliated dentists and family members ... ~, ~ World Impact, Inc.(C) was a key partner, wh...alif., Nov. 11 On Saturday, November 8th,Pacific ...

...sn,t enough evidence to prove its value , ... enough evidence to support a recent American Hear...eart patients for depression, according to interna...About 80 million Americans have some form of heart...

The miseries of allergies just may help prevent some cancers, study finds Hologic Announces Fourth Quarter and Fiscal 2008 Operating Results IPC The Hospitalist Company Reports Record Third Quarter 2008 Results NBA's Kevin Love Helps Launch Rookie Relief for St. Jude Online Jersey Auction Watts Powerhouse Church Receives a Facelift Through the Volunteers of Pacific Dental Services(R)Study Questions Screening Heart Attack Patients for Depression

(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,

(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi

(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in

Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2 U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2 RIT scientist shines laser light on methane in pursuit of clean fuel 10490 1 RIT scientist shines laser light on methane in pursuit of clean fuel 10490 2 Biochemical on switch could solve protein purification challenge 10485 1 Biochemical on switch could solve protein purification challenge 10485 2 Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 1 Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 2 Manipulating brain inflammation may help clear brain of amyloid plaques Mayo Clinic researchers say 59953 3

[0] Amber Pharmacy Earns Accreditation From ACHC [0] Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy [0] U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS

...Kibow Biotech, Inc. is pleased to,announce that it...ion,Treaty (PCT) patent from Australia, China and ...c Compositions and their Method of use for Gut-bas...ehind the Company,s oral,probiotic product formula...duce concentrations of several nitrogenous waste m...

...ed for 10:00 a.m. ET Today, SOUTH SAN FRANCISCO, ... ) today announced that the Independent Data,Monit...wo ongoing Phase 3,clinical trials of GVAX immunot...anned interim analysis and has recommended that th...is was designed to determine whether the,study sho...

Other Medicine Technology:Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 2 Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure 3 Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 2 Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 3 Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 4

Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer

Liquichek Hematology-8 Control

Liquichek Autoimmune Controls - Anti-nDNA

Liquichek Autoimmune Controls - Anti-SS

VARIANTnbs Newborn Hemoglobin Screening System

Medicine Products:

Liquichek Hematology-8 Control Liquichek Autoimmune Controls - Anti-nDNA Liquichek Autoimmune Controls - Anti-SS VARIANTnbs Newborn Hemoglobin Screening System

Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to...(uot; shares Prof Sarbjit who has done ov...),Health